Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Humacyte, Inc.
| Metric | Humacyte, Inc. HUMAHealthcare |
|---|---|
| Quality Score | 29 / 100 |
| Revenue (latest) | $2M |
| Net income (latest) | −$41M |
| Operating margin | −5306.0% |
| Net margin | −2003.6% |
| Return on equity | −1313.4% |
| Return on assets | −35.1% |
| Return on capital (ROCE) | −110.4% |
| Debt / equity | 36.43× |
| Revenue growth (YoY) | — |
| Altman Z″ (distress) | -23.79 |
| Accruals / assets | 55.2% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.